Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Glipizide Xl

Glipizide

Open in the dashboard

Part D claims

7,419

Prescriptions dispensed, refills included

Drug cost

$105,182

Paid at the pharmacy, in all

Prescribers

356

With 11 or more claims of it

In 2024, Medicare Part D recorded 7,419 claims for Glipizide Xl (glipizide) from 356 prescribers, at a total drug cost of $105,182 paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 36 states and territories
Part D claims for Glipizide Xl by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
NY 107 2,254 $22,479
OK 50 1,600 $25,293
PR 67 1,313 $29,995
PA 17 287 $3,098
VA 11 219 $2,739
NJ 12 209 $2,578
GA 9 155 $2,180
FL 10 154 $1,669
CA 7 120 $1,193
WI 3 106 $1,207
IL 6 99 $784
AR 4 96 $1,740
NM 4 75 $925
KY 6 73 $824
TN 3 69 $807
The other 21 states and territories
State Prescribers Claims Drug cost
IN 3 52 $606
MI 4 51 $586
AL 3 50 $679
MA 4 49 $778
VI 4 47 $829
OH 3 39 $630
MD 2 38 $282
NC 2 37 $350
WA 3 35 $327
CT 1 30 $190
UT 1 28 $234
IA 1 21 $559
AZ 1 16 $386
LA 1 14 $108
OR 1 13 $178
CO 1 13 $91
MS 1 12 $84
MT 1 12 $126
SD 1 11 $230
WV 1 11 $370
TX 1 11 $49

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 20
Part D claims for Glipizide Xl by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Internal Medicine 131 2,591 $33,023
Family Practice 84 2,152 $31,005
Nurse Practitioner 50 907 $10,105
General Practice 36 693 $14,589
Physician Assistant 20 388 $5,592
Endocrinology 18 367 $6,759
Cardiology 3 52 $1,226
Emergency Medicine 1 36 $367
Registered Nurse 1 34 $435
Osteopathic Manipulative Medicine 2 33 $354
Legal Medicine 1 32 $244
Pulmonary Disease 1 31 $201
General Surgery 1 15 $68
Interventional Pain Management 1 14 $198
Specialist 1 14 $458

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Byagari Narayana Internal Medicine NY 132 $2,111 None on record
Andrea Coley Nurse Practitioner OK 90 $1,587 None on record
Michael Mason Family Practice OK 81 $1,462 No profile
Cody Mccorkle Family Practice OK 80 $1,202 No profile
Ramon Delmonte Internal Medicine NY 80 $588 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Other names for glipizide

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record